Total Payments
$55,515
2024 Payments
$35,216
Companies
35
Transactions
1,106
Medicare Patients
903
Medicare Billing
$168,802
Payment Breakdown by Category
Other$23,200 (41.8%)
Food & Beverage$19,318 (34.8%)
Consulting$7,250 (13.1%)
Travel$5,571 (10.0%)
Education$176.15 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,200 | 22 | 41.8% |
| Food and Beverage | $19,318 | 1,038 | 34.8% |
| Consulting Fee | $7,250 | 5 | 13.1% |
| Travel and Lodging | $5,571 | 35 | 10.0% |
| Education | $176.15 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $18,214 | 132 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $13,200 | 105 | $0 (2024) |
| Axsome Therapeutics, Inc. | $9,306 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,114 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,963 | 119 | $0 (2024) |
| ITI, Inc. | $1,481 | 81 | $0 (2023) |
| Corium, LLC | $1,163 | 58 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $907.00 | 67 | $0 (2024) |
| Alkermes, Inc. | $735.69 | 38 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $674.31 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,216 | 404 | ABBVIE INC. ($14,939) |
| 2023 | $15,115 | 377 | Teva Pharmaceuticals USA, Inc. ($6,923) |
| 2022 | $2,951 | 184 | Janssen Pharmaceuticals, Inc ($732.31) |
| 2021 | $2,233 | 141 | ITI, Inc. ($556.11) |
All Payment Transactions
1,106 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/24/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ADHD | ||||||
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: ADHD | ||||||
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $79.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neurology | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $83.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: Neurology | ||||||
| 12/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: ADHD | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 134 | 379 | $42,805 | $21,511 |
| 2022 | 6 | 252 | 1,101 | $121,630 | $70,034 |
| 2021 | 7 | 354 | 885 | $85,215 | $52,491 |
| 2020 | 5 | 163 | 457 | $44,030 | $24,767 |
Total Patients
903
Total Services
2,822
Medicare Billing
$168,802
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 303 | $40,905 | $21,247 | 51.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 50 | 76 | $1,900 | $264.24 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 568 | $76,680 | $44,289 | 57.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 369 | $29,520 | $17,861 | 60.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 54 | $6,210 | $3,801 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 56 | $5,320 | $2,503 | 47.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 30 | 30 | $3,300 | $1,487 | 45.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 23 | 24 | $600.00 | $92.11 | 15.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 340 | $27,200 | $17,105 | 62.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 271 | $23,435 | $14,136 | 60.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 86 | $11,180 | $6,849 | 61.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 56 | $9,470 | $6,802 | 71.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 47 | 69 | $7,935 | $4,985 | 62.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 49 | 52 | $5,720 | $2,570 | 44.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 11 | 11 | $275.00 | $44.77 | 16.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 212 | $16,940 | $10,898 | 64.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 135 | $10,800 | $5,941 | 55.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 45 | $5,120 | $3,308 | 64.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 33 | 34 | $7,810 | $3,015 | 38.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 29 | 31 | $3,360 | $1,605 | 47.8% |
About Patrick Cooney
Patrick Cooney is a Physician Assistant healthcare provider based in New Baltimore, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2020. The National Provider Identifier (NPI) number assigned to this provider is 1811527682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Cooney has received a total of $55,515 in payments from pharmaceutical and medical device companies, with $35,216 received in 2024. These payments were reported across 1,106 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,200).
As a Medicare-enrolled provider, Cooney has provided services to 903 Medicare beneficiaries, totaling 2,822 services with total Medicare billing of $168,802. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location New Baltimore, MI
- Active Since 01/21/2020
- Last Updated 01/21/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1811527682
Products in Payments
- VRAYLAR (Drug) $18,214
- UZEDY (Drug) $12,420
- Auvelity (Drug) $9,306
- CAPLYTA (Drug) $2,152
- REXULTI (Drug) $1,714
- INVEGA SUSTENNA (Drug) $1,655
- Azstarys (Drug) $1,020
- INGREZZA (Drug) $907.00
- Dyanavel XR (Drug) $645.95
- HETLIOZ (Drug) $581.38
- QUVIVIQ (Drug) $556.80
- ARISTADA (Drug) $503.67
- ABILIFY MYCITE (Drug) $474.63
- Austedo XR (Drug) $368.96
- QELBREE (Drug) $340.84
- AUSTEDO (Drug) $331.72
- SPRAVATO (Drug) $307.99
- NUEDEXTA (Drug) $305.87
- TRINTELLIX (Drug) $282.46
- LATUDA (Drug) $272.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.